Search Results 1871-1880 of 19966 for Receptor

  1. Publications - Sarah E. James, M.D., Ph.D. - Mayo Clinic

    ... Receptor Pathway Inhibitors. Prostate. 2025 Jul; 85 (10):954-965 Epub 2025 May 01. View PubMed; Gevorkyan GS, Chen Q, Tegtmeier RC, Toesca DS, Laughlin BS ...

  2. Cancer Research News

    ... receptor-T cell therapy featured image. Science Saturday: Addressing the challenges of chimeric antigen receptor-T cell therapy. Marla Broadfoot, Ph.D. August ...

  3. A Study of Pembrolizumab Alone as Therapy for Metastatic Triple-Negative Breast Cancer - Mayo Clinic

    ... receptor (e.g. CTLA-4, OX-40, CD137) or has participated in Merck MK-3475 trials; Known history of human immunodeficiency virus (HIV); Known active Hepatitis ...

  4. A Study Evaluating the Safety and Efficacy of KITE-585 in Subjects With Relapsed/Refractory Multiple Myeloma - Mayo Clinic

    ... receptor (CAR) T-cell therapy, in patients with relapsed/refractory MM (RRMM). Key eligibility criteria included measurable MM and progression, defined by ...

  5. A Study of Pembrolizumab (MK-3475) in Participants With Recurrent or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma - Mayo Clinic

    Human epidermal growth factor receptor 2 (HER-2/neu) negative, or, if HER2/neu positive, must have previously received treatment with trastuzumab. Inclusion ...

  6. Genomic Response Analysis Of Heart Failure Therapy In African Americans - Mayo Clinic

    Background heart failure therapy that includes angiotensin converting enzyme inhibitors (ACEi) or angiotensin receptor blockers (ARBs), and beta blockers ...

  7. A Study to Evaluate the Effectiveness and Safety of PANZYGA in Pediatric Patients with Chronic Immune Thrombocytopenia (ITP) - Mayo Clinic

    Administration of thrombopoietin receptor agonists when the dose has NOT been stable within 3 weeks before enrollment and a dosage change is planned before Day ...

  8. Publications - Elliot L. Dimberg, M.D. - Mayo Clinic

    A systematic review of Gamma-aminobutyric Acid Receptor Type B autoimmunity. Neurol Neurochir Pol. 2019; 53 (1):1-7 Epub 2019 Jan 08. View PubMed; Rubin DI ...

  9. A Study to See if Memantine Protects the Brain During Radiation Therapy Treatment for a Brain Tumor - Mayo Clinic

    Memantine may block receptors (parts of nerve cells) in the brain known to contribute to a decline in cognitive function. Giving memantine may make a ...

  10. A Study Of CNTO 136 (Sirukumab), A Human Anti-IL-6 Monoclonal Antibody, Administered Subcutaneously, In Patients With Active Rheumatoid Arthritis Despite Anti-TNF-Alpha Therapy (SIRROUND-T) - Mayo Clinic

    Has a history of intolerance to tocilizumab that precluded further treatment with it, or inadequate response to 3 months of tocilizumab (anti-IL-6 receptor) ...